Navigation Links
Oncolytics Biotech Inc. Announces Filing of Phase 1/2 Clinical Trial with REOLYSIN(R)
Date:1/3/2008

CALGARY, Jan. 3 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) announced today that the U.S. National Cancer Institute (NCI) has filed a protocol with the U.S. Food and Drug Administration (FDA) for a Phase 1/2 clinical trial for patients with metastatic ovarian, peritoneal or fallopian tube cancers using concurrent systemic and intraperitoneal administration of REOLYSIN(R), Oncolytics' proprietary formulation of the human reovirus. The NCI is sponsoring the trial under its Clinical Trials Agreement with Oncolytics, while Oncolytics will provide clinical supplies of REOLYSIN(R).

The trial, which is being carried out at The Ohio State University Comprehensive Cancer Center, is expected to enroll up to 70 patients with metastatic ovarian, peritoneal or fallopian tube cancers.

These cancer indications were selected after comprehensive preclinical studies carried out by the NCI indicated the reovirus can kill ovarian cancer cells.

The American Cancer Society estimates that more than 22,000 women will be diagnosed with ovarian cancer in the U.S. in 2007, and more than 15,000 will die from it.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit http://www.oncolyticsbiotech.com.

This press release contains forward-looking statements, within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements, including the Company's expectations related to the U.S. NCI Phase I/II systemic and intraperitoneal administr
'/>"/>

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 23rd U.S. Patent
2. Oncolytics Biotech Inc. Reports Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
3. Media Advisory - Oncolytics Biotech Inc. to Present at BioPartnering Europe
4. Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007
5. Oncolytics Biotech Inc. Announces Approval for U.K. Clinical Trial Investigating REOLYSIN(R) in Combination with Cyclophosphamide
6. Oncolytics Biotech Inc. Collaborators to Present Positive Interim Results of U.K. Phase Ia/Ib Combination REOLYSIN(R) and Radiation Clinical Trial
7. Oncolytics Biotech Inc. Announces 2007 Third Quarter Results
8. Media Advisory - Oncolytics Biotech Inc. to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9. Media Advisory - Oncolytics Biotech Inc. to Present at Toronto CFA Society
10. Oncolytics Biotech Inc. Announces Issuance of 24th U.S. Patent
11. Oncolytics Biotech Inc. to Present at Annual Vaccine Production Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/11/2009)... -- EntreMed, Inc. (Nasdaq: ENMD ), today ... revenue from sales of Thalomid® during the third ... million. In addition, the Company anticipates a ... fiscal 2009. The difference in estimated and ... reflected in the fourth quarter financial results. ,, ...
(Date:12/11/2009)... MA (12/11/2009) Boston College researchers have observed the ... first time and successfully harvested the elusive charges using ... solar power efficiency, the authors report in the current ... When light is captured in solar cells, it generates ... in order to snare these charges, the electrons must ...
(Date:12/11/2009)... Mass., Dec. 11 Gwathmey, Inc., ... specializing in cancer, staph aureus, and cardiovascular disease ... Services announced today that Rosalie Dunn, Ph.D., has ... Dunn has over 28 years of experience working ... Prior to joining Gwathmey, Dr. Dunn managed multimillion ...
(Date:12/10/2009)... 10 Microban International, Ltd., the ... has partnered with Sharp Imaging and Information ... Electronics, to incorporate it,s third generation silver-based ... Infused into the calculator keys during manufacture, ... growth of damaging bacteria on the keys. ...
Breaking Biology Technology:EntreMed Reports Receipt of Third Quarter Royalty Payment 2Elusive 'hot' electrons captured in ultra-thin solar cells 2Rosalie Dunn, Ph.D., Joins Gwathmey, Inc. as Chief Executive Officer 2Microban Signs Exclusive Agreement with Sharp Electronics to Launch Calculators with New Microban(R) 3G Silver(TM) Antimicrobial Technology 2
... whispering galleries where words spoken softly beneath a ... heard on the opposite side of the chamber ... be a significant breakthrough in the miniaturization of lasers. ... intriguing applications, including superfast communications and data handling (photonics), ...
... 23 Aerolase Corporation, a leading manufacturer of ... announced that sales increased dramatically in 2008 over ... aesthetic laser market helped to more than offset ... was a record sales month for Aerolase, and ...
... XTNT ) today announced that it plans to ... alternatives which may include the sale of some or all ... acquisition transactions intended to maximize shareholder value."Given the continued challenges ... the best interests of the shareholders to consider strategic options," ...
Other Biology Technology:Plasmonic whispering gallery microcavity paves the way to future nanolasers 2Plasmonic whispering gallery microcavity paves the way to future nanolasers 3Plasmonic whispering gallery microcavity paves the way to future nanolasers 4Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers 2Aerolase Reports Strong Sales in 2008 for Portable Aesthetic Lasers 3XTENT to Retain Investment Bank to Pursue Strategic Alternatives 2XTENT to Retain Investment Bank to Pursue Strategic Alternatives 3
(Date:12/11/2009)... available in French . , Montreal, ... novel molecular mechanism that prevents cancer. In the December ... , scientists from the Universit de Montral and the ... SOCS1 molecule prevents the cancer-causing activity of cytokines, hormones ... as Crohns, in smokers and people exposed to asbestos. ...
(Date:12/11/2009)... been limited by the seasons, particularly in ... short. Thanks to researchers and fruit breeders, ... offer growers the ability to produce fruit ... both producers and consumers. Fresh examples are ... which bear fruit on current-season canes, or ...
(Date:12/11/2009)... roe of hake, lumpsucker and salmon is the best dietary ... by researchers at the University of Almera (UAL). The scientists ... found all of these contained high levels of these fatty ... now there had been no precise understanding of the nutritional ... of researchers from the UAL has now shown that this ...
Breaking Biology News(10 mins):Scientists identify natural anti-cancer defenses 2New management methods extend blackberry season 2Roe of marine animals is best natural source of omega-3 2Twenty Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 55413 1Twenty Two Regional Construction Firms Recognized for Their Commitment to Worker Safety 55413 2VA Continues Gulf War Research Cancels Contract with UTSW Medical Center 55411 1VA Continues Gulf War Research Cancels Contract with UTSW Medical Center 55411 2Randall Terry Removed By Police From Howard Dean Health Care Town Hall Meeting 55409 1Randall Terry Removed By Police From Howard Dean Health Care Town Hall Meeting 55409 2
... the Climate Change category has found its way, in this ... than three decades ago predicted the existence of climate warming ... "Climate Change: Are We on the Brink of a Pronounced ... first ever mention of the term "global warming" in a ...
... known as the deserts of the sea. And yet this ... fertile coral reef grows. Dutch researcher Jasper de Goeij investigated ... existence. Although sponges in these coral caves take up a ... do discard a lot of cells that in turn provide ...
... -- The official State Dinosaur of Texas is up for ... proved the titleholder has been misidentified. , State Rep. Charles ... change the name of the state dinosaur from Pleurocoelus ... massive sauropod ,whose tracks and bones litter the central Texas ...
Other Biology News:Wallace S. Broecker wins the BBVA Foundation Frontiers of Knowledge Award in Climate Change 2Voracious sponges save reef 2A case of mistaken dino-identity 2
... reads and processes raw microarray ... data for analysis. ,Package ... 2-year license for Feature Extraction ... * one CD-ROM containing ...
... Automatic grid, subgrid and spot finding overcome tedious spot, ... template assignment , ... and signal options to optimize, ... results , Characterize more precisely through grouping by ...
... and SYBR Safe DNA Gel Stain combo offers these ... buying these same products separately ... bromide Eliminates risks to ... and RNA fragments from 100 bp to >30 kb. ...
... E.Coli glycerol stocks contained in standard 96-well ... clones with approximately 5,000 clones per plate. ... plate well, the corresponding subplate is screened ... the positive well(s). Cells from a positive ...
Biology Products: